StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Tuesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Stock Down 5.1 %

Shares of MLSS opened at $0.58 on Tuesday. The firm has a market cap of $44.25 million, a PE ratio of -5.78 and a beta of 0.98. The company’s fifty day moving average is $0.67 and its two-hundred day moving average is $0.72. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.35.

Milestone Scientific (NYSE:MLSS) last posted its earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. The business had revenue of $2.26 million for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.

Institutional Investors Weigh In On Milestone Scientific

Several hedge funds and other institutional investors have recently modified their holdings of MLSS. Citadel Advisors LLC increased its position in shares of Milestone Scientific by 599.9% in the 2nd quarter. Citadel Advisors LLC now owns 156,422 shares of the company’s stock worth $143,000 after purchasing an additional 134,073 shares during the last quarter. Carnegie Capital Asset Management LLC bought a new stake in shares of Milestone Scientific during the 3rd quarter valued at about $121,000. Sequoia Financial Advisors LLC bought a new stake in shares of Milestone Scientific during the 1st quarter valued at about $86,000. Virtu Financial LLC grew its position in shares of Milestone Scientific by 370.1% during the 4th quarter. Virtu Financial LLC now owns 67,265 shares of the company’s stock valued at $32,000 after buying an additional 52,957 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Milestone Scientific by 13.0% during the 2nd quarter. Geode Capital Management LLC now owns 413,992 shares of the company’s stock valued at $360,000 after buying an additional 47,777 shares during the last quarter. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.